AN EXPERT TEAM SUPPORTING INNOVATIVE ADVANCES IN NEUROSCIENCE STUDIES

Neuroscience

Access a unique combination of science, expertise and data to enable a successful delivery of your neuroscience clinical trial.

Apply our scientifically rigorous patient-centric strategy to reduce the participation burden and increase the value of your study.

Optimize your clinical research with our innovative product development methods for advanced neuroscience therapies and precision medicines.

Get a dedicated team for your neuroscience product.

Let's Connect

Enabling a successful study in neuroscience and neurodegenerative diseases requires the support of a dedicated science-driven and therapeutically experienced team. At Fortrea, we understand the complexities and needs of these studies from early phase through post-marketing and beyond.

Our cross-functional SMEs offer in-depth knowledge of drug development in neuroscience and customized strategies to help accelerate your timelines and get your therapy to market faster.

Whether we are advancing your drug, device or combination product, we’ll act as an extension of your team, forming a culture of collaboration that addresses your unique needs. Together, let’s agilely navigate the challenges of neuroscience, transform your product development and create an exceptional partnership.

Experience matters when choosing a partner.

Across the Americas, UK/EU, Asia Pacific, Middle East and Africa, we’ve supported complex trials and advanced clinical research on neuroscience and neurodegenerative disorders. 

In the last 5 years
We’ve been honored to serve as a CRO partner of choice for our biotech and pharmaceutical customers as we’ve advanced their neuroscience drug development and supported:

437

Neurology Studies

6,117

Sites

46,025

Patients

Our top areas of neuroscience expertise

Neurodegenerative disorders

  • Alzheimer's Disease (AD)
  • Parkinson’s Disease (PD)
  • Multiple Sclerosis (MS)

Psychiatric disorders

  • Autism Spectrum Disorder
  • ADHD
  • Schizophrenia

Pain

  • Chronic
  • Acute
  • Migraine
  • Neuropathies

Rare neurological disorders

  • Fragile X syndrome (FXS)
  • Mucopolysaccharidosis
  • Muscular Dystrophies
  • Batten Disease

Other neuroscience areas

  • Epilepsy
  • Stroke

Explore our related areas of expertise
Rare Diseases   |   Cell and Gene Therapies   |  Pediatrics

Enable effective, patient-centric strategies.

Understandably, within the entire field of neuroscience, there are a broad range of disorders such as neurodegenerative, developmental, psychiatric, acute critical care, as well as special patient populations like elderly or pediatric that are highly sensitive to risks that arise from age- or mental- related challenges, non-compliance and psychological instability.

Our clinical studies experts at Fortrea have pioneered innovative approaches to recruit and retain these individuals and we offer insightful methods for wet, tissue, imaging and digital biomarker collection to support precision medicine. Coupled with our commitment to patient and caregiver centricity through our real-world data and partnerships with patient advocacy groups, we can help optimize protocols and increase the likelihood of your trial’s success.

Leverage our partnerships for your neuroscience study.

Increase the chances for meeting your program objectives by selecting the right endpoints by leveraging our established strategic partnerships with vendors who have strong expertise in neuro-specific clinical outcome assessment (COA), imaging and digital technology. Combining their expertise with our multifaceted neuroscience clinical expertise at Fortrea, we can support your selection of the right neurological outcome measures, enable continuous rating surveillance to monitor the integrity of your endpoints and ultimately maximize the differentiation of your product.

Select high-performing sites across your program.

Advance your program with the right, high-performing sites. We have strong partnerships and experience working with neuroscience-specialized sites, allowing us to reduce your trial’s startup time. Augmented with the industry’s deepest performance data, we can help you find investigators with the highest chances of success. We also offer the benefit of our practical experience gained from developing methods and training sites on the application of complex routes of administration, such as intrathecal or intracerebral delivery.

Beyond our existing partnerships with sites, we are constantly pursuing additional sites as we expand our network globally—including sites in emerging regions such as Latin America, Asia and Africa—to continuously optimize patient recruitment. 

Get to know us.

“I’ve focused my clinical research career on neuroscience because of the field's tremendous impact on human health and society. I continue to be inspired by our dedication at Fortrea as we support complex drug development pathways and help advance innovative, life-changing therapies. Together with our clients, we have the potential to enable early intervention, slow progression or even prevent disease manifestation in some of today’s most challenging diseases.” 
–Tetyana Korchak, MD 

An exceptional partnership starts with an experienced team. Browse the bios of our featured neuroscience team members.

Vikas Mohan Sharma, MD Vice President & Global Head
Laurentiu Gutiu, MD Executive Medical Director
Antoniya Todorova, MD, PhD Medical Director
Francisco Martinez-Torres, MD, PhD Senior Medical Director
Meet the team

Get the latest updates from our neuroscience team.

We’re sharing our latest news, events and publications.

White Paper
 Precision medicines for neurodegenerative disorders: optimizing clinical development.
Read the paper
case study
 Applying a patient- and site-centric approach in an early Phase I Alzheimer’s Disease study.
Read study
Article
 Sharing our best patient-centric practices from extensive experience in Alzheimer’s Disease.
Read article

Stay up to date:
Subscribe for Fortrea news & announcements.

Subscribe Now